Molina Healthcare, Inc. (NYSE:MOH) Position Trimmed by Marshall Wace LLP

Marshall Wace LLP reduced its position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 25.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 53,584 shares of the company's stock after selling 18,237 shares during the period. Marshall Wace LLP owned about 0.09% of Molina Healthcare worth $15,596,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Waldron Private Wealth LLC lifted its holdings in Molina Healthcare by 4.7% in the 4th quarter. Waldron Private Wealth LLC now owns 729 shares of the company's stock worth $212,000 after buying an additional 33 shares in the last quarter. Angeles Investment Advisors LLC boosted its holdings in Molina Healthcare by 5.4% in the fourth quarter. Angeles Investment Advisors LLC now owns 838 shares of the company's stock valued at $244,000 after purchasing an additional 43 shares during the last quarter. Lindbrook Capital LLC grew its stake in Molina Healthcare by 38.5% during the 4th quarter. Lindbrook Capital LLC now owns 205 shares of the company's stock valued at $60,000 after purchasing an additional 57 shares in the last quarter. Quadrant Capital Group LLC increased its holdings in Molina Healthcare by 11.4% during the 4th quarter. Quadrant Capital Group LLC now owns 627 shares of the company's stock worth $182,000 after purchasing an additional 64 shares during the last quarter. Finally, Brooklyn Investment Group boosted its stake in shares of Molina Healthcare by 20.1% during the 4th quarter. Brooklyn Investment Group now owns 400 shares of the company's stock valued at $116,000 after buying an additional 67 shares during the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Molina Healthcare

In related news, Director Steven J. Orlando sold 1,000 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the sale, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. The trade was a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.10% of the company's stock.

Molina Healthcare Stock Performance

Shares of NYSE:MOH traded down $17.62 during trading hours on Thursday, hitting $314.38. The stock had a trading volume of 1,476,265 shares, compared to its average volume of 672,883. The stock's fifty day simple moving average is $318.47 and its 200 day simple moving average is $307.75. The firm has a market capitalization of $17.20 billion, a price-to-earnings ratio of 15.39, a PEG ratio of 1.06 and a beta of 0.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. Molina Healthcare, Inc. has a 1-year low of $262.32 and a 1-year high of $370.99.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, beating the consensus estimate of $5.86 by $0.22. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The firm had revenue of $11.15 billion for the quarter, compared to analysts' expectations of $10.86 billion. During the same period last year, the firm earned $5.73 EPS. Sell-side analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Barclays dropped their price target on shares of Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating for the company in a research note on Friday, February 7th. Guggenheim started coverage on shares of Molina Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating on the stock. UBS Group reduced their price target on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a research report on Friday, February 7th. StockNews.com upgraded Molina Healthcare from a "hold" rating to a "buy" rating in a research report on Friday, April 11th. Finally, Baird R W lowered Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Nine analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $363.62.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.